Literature DB >> 36244036

Dynorphin participates in interaction between depression and non-erosive reflux disease.

Yi Wang1, Bingduo Zhou1, Shengquan Fang1, Shengliang Zhu1, Tingting Xu1, Makan Dilikumaer1, Guanwu Li2.   

Abstract

BACKGROUND: To explore the relationships between anxiety/depression and NERD, we focused on dynorphin (Dyn), an important member of visceral hypersensitivity, and its related pathways.
METHODS: Pearson's correlation analysis on patients with NERD and in vivo experiment on NERD rat model. Part 1: Pearson's correlation analysis among serum levels of Dyn, clinical symptoms and HADS scores of NERD patients were carried on. Part 2: Wistar rats were randomly divided into 2 groups: control group and model group. The data of pH value, immobility time, serum Dyn concentration, NMDAR1 and SP expression were, respectively, derived from automatic pH recorder, tail suspension test, enzyme-linked immunosorbent assay, immunohistochemistry and immunofluorescence.
RESULTS: Part 1: Pearson's correlation analysis showed that there was a linear correlation between Clinical Symptom (CS) score and HADS score (HAD-A, HAD-D), and the correlation coefficients were 0.385 and 0.273 respectively; the correlation coefficient between lg (Dyn) and lg (CS score) was r = 0.441, P = 0.002; the correlation coefficient between lg(Dyn) and lg (HAD-D score) was r = 0.447, P = 0.002. Part 2: The pH value of the lower esophagus in the model group was lower than that in the control group (P < 0.01). The tail suspension immobility time of model group was significantly longer than that of control group (P < 0.01). The serum Dyn concentration and the expression level of NMDAR1 in spinal cord and SP in lower esophageal mucosa of model group were significantly higher than those of control group (P < 0.05).
CONCLUSION: Increased serum dynorphin level may be a sign of correlation between depression and NERD.
© 2022. The Author(s).

Entities:  

Keywords:  Depression; Dynorphin; Hospital Anxiety and Depression Scale; Hypersensitivity; N-methyl-D-aspartate; Non-erosive reflux disease

Year:  2022        PMID: 36244036     DOI: 10.1007/s10388-022-00955-0

Source DB:  PubMed          Journal:  Esophagus        ISSN: 1612-9059            Impact factor:   3.671


  47 in total

1.  Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis.

Authors:  M Frazzoni; R Conigliaro; G Melotti
Journal:  Aliment Pharmacol Ther       Date:  2010-12-29       Impact factor: 8.171

Review 2.  Mechanisms of reflux perception in gastroesophageal reflux disease: a review.

Authors:  Albert J Bredenoord
Journal:  Am J Gastroenterol       Date:  2012-01       Impact factor: 10.864

3.  Gastroesophageal Reflux and Sleep Disturbances: A Bidirectional Association in a Population-Based Cohort Study, The HUNT Study.

Authors:  Anna Lindam; Eivind Ness-Jensen; Catarina Jansson; Helena Nordenstedt; Torbjörn Åkerstedt; Kristian Hveem; Jesper Lagergren
Journal:  Sleep       Date:  2016-07-01       Impact factor: 5.849

4.  Influence of the pH Value of Refluxate and Proximal Extent on Heartburn Perception in Patients with Proton Pump Inhibitor-Refractory Non-Erosive Reflux Disease.

Authors:  Yasuaki Abe; Tomoyuki Koike; Masahiro Saito; Tomoki Okata; Kazuaki Norita; Hiroki Kikuchi; Kenichiro Nakagawa; Waku Hatta; Kiyotaka Asanuma; Kaname Uno; Naoki Asano; Akira Imatani; Tooru Shimosegawa; Atsushi Masamune
Journal:  Digestion       Date:  2019-07-29       Impact factor: 3.216

5.  Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study.

Authors:  Nikos Viazis; Anastasia Keyoglou; Alexandros K Kanellopoulos; George Karamanolis; John Vlachogiannakos; Konstantinos Triantafyllou; Spiros D Ladas; Dimitrios G Karamanolis
Journal:  Am J Gastroenterol       Date:  2011-05-31       Impact factor: 10.864

6.  Nonerosive Reflux Disease (NERD) - An Update.

Authors:  Tiberiu Hershcovici; Ronnie Fass
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

7.  The role of weakly acidic reflux in proton pump inhibitor failure, has dust settled?

Authors:  Emmanouela Tsoukali; Daniel Sifrim
Journal:  J Neurogastroenterol Motil       Date:  2010-07-27       Impact factor: 4.924

8.  Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus.

Authors:  Kwong Ming Fock; Nicholas Talley; Khean Lee Goh; Kentaro Sugano; Peter Katelaris; Gerald Holtmann; John E Pandolfino; Prateek Sharma; Tiing Leong Ang; Michio Hongo; Justin Wu; Minhu Chen; Myung-Gyu Choi; Ngai Moh Law; Bor-Shyang Sheu; Jun Zhang; Khek Yu Ho; Jose Sollano; Abdul Aziz Rani; Chomsri Kositchaiwat; Shobna Bhatia
Journal:  Gut       Date:  2016-06-03       Impact factor: 23.059

9.  Risk factors for erosive and non-erosive gastroesophageal reflux disease and Barrett's esophagus in Nothern Sardinia.

Authors:  Maria Pina Dore; Giovanni Mario Pes; Gabrio Bassotti; Maria Antonietta Farina; Giuseppina Marras; David Yates Graham
Journal:  Scand J Gastroenterol       Date:  2016-07-05       Impact factor: 2.423

Review 10.  Role of non-acid reflux in patients with non-erosive reflux disease.

Authors:  Georgios P Karamanolis; Radu Tutuian
Journal:  Ann Gastroenterol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.